Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zijian Fang
Differences in Signalling, Trafficking and Glucoregulatory Properties of Glucagon-Like Peptide-1 Receptor Agonists Exendin-4 and Lixisenatide
Related publications
Synthesis and Biological Evaluation of Glucagon-Like Peptide-1 Receptor Agonists
Archives of Pharmacal Research
Organic Chemistry
Drug Discovery
Molecular Medicine
The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice
Physiology and Behavior
Philosophy
Behavioral Neuroscience
Experimental
Cognitive Psychology
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
PLoS ONE
Multidisciplinary
Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management
South African Family Practice
Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Clinical Drug Investigation
Medicine
Pharmacology
Equine Glucagon-Like Peptide-1 Receptor Physiology
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience